FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition of human calcitonin gene peptide has liposomes made of natural soybean phospholipid in the weight ratio of human calcitonin gene peptide to phospholipid = (1-2):(100-8000). Half-life value for composition is above 72 h. Composition can be administrated by intravenous route, by mucusa mouth and nose spraying in the dose 0.1-10 pg of human calcitonin gene peptide/kg of body mass for treatment of patients with hypertension and congested cardiac insufficiency. Biological availability of composition is about 80%. Invention provides effective prophylaxis and treatment of cardiovascular diseases. EFFECT: enhanced effectiveness, prolonged stability of composition. 8 cl, 8 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
| USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME | 2021 |
|
RU2821030C1 |
| IRINOTECAN LIPOSOMES OR ITS SALTS, METHOD FOR PREPARING THEM | 2009 |
|
RU2526114C2 |
| LIPOSOME HAVING INNER AQUEOUS PHASE AND CONTAINING SULPHOBUTYL ESTER CYCLODEXTRIN SALT | 2010 |
|
RU2575793C2 |
| LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
| METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
| APPLICATION OF MITOXANTHONE HYDROCHLORIDE LIPOSOM FOR THE TREATMENT OF BREAST CANCER | 2021 |
|
RU2806277C1 |
| SYNTHETIC MEMBRANE VESICLES CONTAINING FUNCTIONALLY-ACTIVE FUSED PEPTIDES AS SYSTEMS FOR ADMINISTRATION OF PHARMACEUTICAL MEANS, METHOD OF PREPARATION THEREOF, AND THEIR APPLICATION FOR PREPARING ANTI-AIDS MEANS | 1992 |
|
RU2125868C1 |
| LIPOSOMES CONTAINING CELL PENETRATING PEPTIDES AND TETRAESTER LIPIDS FOR ORAL DELIVERY OF MACROMOLECULES | 2016 |
|
RU2743431C2 |
| USE OF MITOXANTHRON LIPOSOME FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMA | 2019 |
|
RU2804477C2 |
